A Study of LY3361237 in Participants With Psoriasis
Clinical trial NCT04975295 · COMPLETED
Trial details
- NCT number
- NCT04975295
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-27
- Primary completion
- 2022-11-29
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.